Assignee
HETERO LABS LTD
IN·15 granted patents·8 pending applications·17 citations·filing 2015–2021
Top patents by PatentIndex Score
23 records- 0184US10214497B2Process for the preparation of a dual-acting angiotensin receptor-neprilysin inhibitor compoundHETERO LABS LTD·Filed 2016·Granted Feb 26, 2019·5 cites·4 claims
- 0283US11034718B2C-3 novel triterpenone with C-17 reverse amide derivatives as HIV inhibitorsHETERO LABS LTD·Filed 2019·Granted Jun 15, 2021·2 cites·10 claims
- 0383US9868758B2Betulinic proline imidazole derivatives as HIV inhibitorsHETERO LABS LTD·Filed 2015·Granted Jan 16, 2018·3 cites·13 claims
- 0480US10562867B2Process for the preparation of a dual-acting angiotensin receptor-neprilysin inhibitor compoundHETERO LABS LTD·Filed 2018·Granted Feb 18, 2020·2 cites·3 claims
- 0580US10533035B2C-3 novel triterpenone with C-17 reverse amide derivatives as HIV inhibitorsHETERO LABS LTD·Filed 2016·Granted Jan 14, 2020·2 cites·11 claims
- 0676US10329281B2Polymorphs and process for the preparation of quinazolinyl derivativesHETERO LABS LTD·Filed 2016·Granted Jun 25, 2019·3 cites·14 claims
- 0773US10822314B2Process for the preparation of a dual-acting angiotensin receptor-neprilysin inhibitor compoundHETERO LABS LTD·Filed 2019·Granted Nov 3, 2020·0 cites·2 claims
- 0859US12275712B2Triterpene derivatives as HIV inhibitorsHETERO LABS LTD·Filed 2020·Granted Apr 15, 2025·0 cites·10 claims
- 0949US11655220B2Process for the preparation of angiotensin II receptor blockersHETERO LABS LTD·Filed 2021·Granted May 23, 2023·0 cites·6 claims
- 1047US12378281B2Triterpenone derivatives as HIV inhibitorsHETERO LABS LTD·Filed 2020·Granted Aug 5, 2025·0 cites·5 claims
- 1145US2018280364A1Pharmaceutical compositions of sodium picosulfate, magnesium oxide and citric acidHETERO LABS LTD·Filed 2018·Application pending·0 cites
- 1245US2023174570A1Novel triterpene derivatives as hiv inhibitorsHETERO LABS LTD·Filed 2021·Application pending·0 cites
- 1344US11020351B2Stable bilayer tablet compositionsHETERO LABS LTD·Filed 2018·Granted Jun 1, 2021·0 cites·10 claims
- 1444US2020078309A1Stable tablet compositions of Sacubitril: ValsartanHETERO LABS LTD·Filed 2019·Application pending·0 cites
- 1543US2021230155A1Process for preparation of ((3r,11br)-1,3,4,6,7,11b-hexahydro-9,10-di(methoxy-d3)-3-(2-methylpropyl)-2h-benzo[a]quinolizin-2-oneHETERO LABS LTD·Filed 2019·Application pending·0 cites
- 1642US2019336478A1Stable oral liquid compositions of enalaprilHETERO LABS LTD·Filed 2019·Application pending·0 cites
- 1741US11471447B2Stable pharmaceutical product and vessel comprising sodium picosulfate, magnesium oxide and citric acidHETERO LABS LTD·Filed 2020·Granted Oct 18, 2022·0 cites·7 claims
- 1839US10669305B2C-3 novel triterpenone with C-28 urea derivatives as HIV inhibitorsHETERO LABS LTD·Filed 2016·Granted Jun 2, 2020·0 cites·11 claims
- 1937US2019175511A1A Multi-Class Anti-Retroviral CompositionHETERO LABS LTD·Filed 2017·Application pending·0 cites
- 2032US2019175509A1High Drug Loaded Tablet Composition for Treating HIVHETERO LABS LTD·Filed 2017·Application pending·0 cites
- 2131US11045423B2Anti-retroviral compositionsHETERO LABS LTD·Filed 2017·Granted Jun 29, 2021·0 cites·9 claims
- 2230US10370405B2C-3 novel triterpenone with C-28 amide derivatives as HIV inhibitorsHETERO LABS LTD·Filed 2016·Granted Aug 6, 2019·0 cites·9 claims
- 2328US2018064653A1Pharmaceutical compositions of dimethyl fumarateHETERO LABS LTD·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when HETERO LABS LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →